NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM; NAPROXEN) — FDA Approval ANDA217738 (SCIEGEN PHARMS)
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM; NAPROXEN) — FDA Approval ANDA217738 (SCIEGEN PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM; Active ingredients: ESOMEPRAZOLE MAGNESIUM; NAPROXEN; Application number: ANDA2177
| Brand name | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
|---|---|
| Active ingredients | ESOMEPRAZOLE MAGNESIUM; NAPROXEN |
| Application number | ANDA217738 |
| Sponsor | SCIEGEN PHARMS |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20231011 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →